Currently out of the existing stock ratings of Matthew Akers, 22 are a SELL (6.98%), 132 are a HOLD (41.9%), 161 are a BUY (51.11%).

Matthew Akers

Work Performance Price Targets & Ratings Chart

Analyst Matthew Akers, currently employed at WELLS FARGO, carries an average stock price target met ratio of 87.1% that have a potential upside of 17.89% achieved within 186 days.

Matthew Akers’s has documented 620 price targets and ratings displayed on 22 stocks. The coverage is on Industrials, Technology, Communication Services sectors.

Most recent stock forecast was given on SAIC, Science Applications International Corp at 04-Jun-2025.

Wall Street Analyst Matthew Akers

Analyst best performing recommendations are on MANT (MANTECH INTERNATIONAL).
The best stock recommendation documented was for MANT (MANTECH INTERNATIONAL) at 11/3/2021. The price target of $80 was fulfilled within 1 day with a profit of $2.29 (2.95%) receiving and performance score of 29.47.

Average potential price target upside

BA The Boeing Company BAH Booz Allen Hamilton CACI CACI International GD General Dynamics LHX L3Harris Technologies LMT Lockheed Martin MANT ManTech International NOC Northrop Grumman LDOS Leidos Holdings SAIC Science Applications International Corp HWM Howmet Aerospace  MAXR Maxar Technologies RTX Raytheon Technologies Corp TDG Transdigm Group WWD Woodward SPCE Virgin Galactic Holdings GE General Electric Company HXL Hexcel OSIS OSI Systems RKLB Rocket Lab USA MAN ManpowerGroup MAX MediaAlpha

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Dec-2025

$295

$77.75 (35.79%)

$290

2 months 11 days ago
(29-Apr-2026)

0/3 (0%)

$70.89 (31.63%)

Hold Since 15-Mar-2023

$250

$32.75 (15.07%)

$235

2 months 17 days ago
(23-Apr-2026)

29/41 (70.73%)

$15.85 (6.77%)

142

Buy Since 12-Dec-2025

$256

$38.75 (17.84%)

$290

3 months 8 days ago
(02-Apr-2026)

0/4 (0%)

$47.78 (22.95%)

Buy Since 02-May-2025

$250

$32.75 (15.07%)

$255

3 months 9 days ago
(01-Apr-2026)

11/14 (78.57%)

$42.68 (20.59%)

127

Buy Since 06-Sep-2018

$295

$77.75 (35.79%)

$255

5 months 8 days ago
(02-Feb-2026)

18/60 (30%)

$61.98 (26.60%)

236

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Matthew Akers?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?